Reduced nicotine reward in obesity: cross-comparison in human and mouse

被引:66
作者
Blendy, JA
Strasser, A
Walters, CL
Perkins, KA
Patterson, F
Berkowitz, R
Lerman, C
机构
[1] Dept Pharmacol, Philadelphia, PA 19104 USA
[2] Dept Psychiat, Tobacco Use Res Ctr, Philadelphia, PA 19104 USA
[3] Univ Pittsburgh, Sch Med, Dept Psychiat, WPIC, Pittsburgh, PA 15213 USA
[4] Childrens Hosp Philadelphia, Dept Psychiat, Philadelphia, PA 19104 USA
关键词
nicotine; smoking; obesity;
D O I
10.1007/s00213-005-2167-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: Tobacco use and obesity lead to significant morbidity and mortality. Objective: This study was conducted to investigate the factors maintaining smoking behavior in lean and obese individuals by utilizing a mouse/human cross-validation model of nicotine reward. Methods: In humans, a cigarette choice paradigm was used to examine the relative reinforcing value of nicotine in obese and non-obese smokers. Conditioned place preference (CPP) for nicotine was assessed in mice fed standard low fat rodent chow and mice rendered obese by a high fat diet. Results: In humans, obese smokers self-administered nicotine via cigarettes significantly less often than non-obese smokers and showed attenuated hedonic effects of nicotine-containing cigarettes compared to denicotinized cigarettes. Similarly, mice exposed to a high fat diet did not exhibit nicotine CPP, relative to control mice. mRNA levels for mu-opiate and leptin receptors were also down-regulated in the ventral tegmental area of these mice. Conclusions: Together, these studies provide the first evidence for reduced nicotine reward in obese subjects and suggest that this may be mediated by dietary influences on the endogenous opioid system.
引用
收藏
页码:306 / 315
页数:10
相关论文
共 72 条
[1]   ENDOGENOUS OPIOIDS - BIOLOGY AND FUNCTION [J].
AKIL, H ;
WATSON, SJ ;
YOUNG, E ;
LEWIS, ME ;
KHACHATURIAN, H ;
WALKER, JM .
ANNUAL REVIEW OF NEUROSCIENCE, 1984, 7 :223-255
[2]   Conditioned place preference: what does it add to our preclinical understanding of drug reward? [J].
Bardo, MT ;
Bevins, RA .
PSYCHOPHARMACOLOGY, 2000, 153 (01) :31-43
[3]   Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight [J].
Baskin, DG ;
Lattemann, DF ;
Seeley, RJ ;
Woods, SC ;
Porte, D ;
Schwartz, MW .
BRAIN RESEARCH, 1999, 848 (1-2) :114-123
[4]   EFFECTS OF STREPTOZOTOCIN-INDUCED DIABETES ON PRODYNORPHIN-DERIVED PEPTIDES IN RAT-BRAIN REGIONS [J].
BERMAN, Y ;
DEVI, L ;
CARR, KD .
BRAIN RESEARCH, 1995, 685 (1-2) :129-134
[5]  
Berrendero F, 2002, J NEUROSCI, V22, P10935
[6]   Predictors of quitting and dropout among women in a clinic-based smoking cessation program [J].
Borrelli, B ;
Hogan, JW ;
Bock, B ;
Pinto, B ;
Roberts, M ;
Marcus, B .
PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 2002, 16 (01) :22-27
[7]  
Brauer L H, 2001, Nicotine Tob Res, V3, P101
[8]   Naltrexone blockade of nicotine effects in cigarette smokers [J].
Brauer, LH ;
Behm, FM ;
Westman, EC ;
Patel, P ;
Rose, JE .
PSYCHOPHARMACOLOGY, 1999, 143 (04) :339-346
[9]   NICOTINIC EXCITATION OF RAT VENTRAL TEGMENTAL NEURONS INVITRO STUDIED BY INTRACELLULAR-RECORDING [J].
CALABRESI, P ;
LACEY, MG ;
NORTH, RA .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 98 (01) :135-140
[10]   Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].
Calle, EE ;
Rodriguez, C ;
Walker-Thurmond, K ;
Thun, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638